SALT LAKE CITY, May 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced seven new commercial coverage decisions for Prolaris ...

In a groundbreaking decision issued May 21, 2025, the Michigan Court of Appeals handed down a pivotal win for car crash victims across the state, particularly those injured by a negligent family ...

A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...

In recent years, the integration of artificial intelligence (AI) into various sectors has been nothing short of revolutionary. One such sector experiencing transformative change is health insurance, ...

The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.